Moderna Omicron booster cleared in Canada for children and adolescents
Moderna $Moderna, Inc.(MRNA)$
Accordingly, the messenger-RNA-based bivalent vaccine, mRNA-1273.214, will be allowed as a booster shot in Canada for children and adolescents who have completed a primary series with any authorized COVID shot or a previous booster.
The authorization limits mRNA-1273.214 dosage to 25 μg for children aged 6 – 11 years and 50 μg booster dose for adolescents aged 12 -17 years.
Canada has previously authorized mRNA-1273.214 and the company’s BA.4/ BA.5 targeting Omicron booster mRNA.1273.222 for use in those aged 18 years and above.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Ok